Albumin-bilirubin score is associated with response to pegylated interferon and nucleos(t)ide analogues in chronic hepatitis B patients

首页> 外文期刊>Clinica chimica acta: International journal of clinical chemistry and applied molecular biology >Albumin-bilirubin score is associated with response to pegylated interferon and nucleos(t)ide analogues in chronic hepatitis B patients

【24h】

Albumin-bilirubin score is associated with response to pegylated interferon and nucleos(t)ide analogues in chronic hepatitis B patients

机译：白蛋白 - 胆红素评分与慢性乙型肝炎患者中的聚乙二醇化干扰素和核苷类IDE类似物有关

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background and aim: Recently, the role of albumin-bilirubin (ALBI) score in chronic hepatitis B (CHB) has not been well-understood. We aimed to investigate the association of ALBI score with natural history of chronic HBV infection and treatment response of CHB patients.

机译：背景和目的：最近，白蛋白 - 胆红素（Albi）评分在慢性乙型肝炎（CHB）中的作用尚未得到很好的理解。我们的旨在调查Albi评分与慢性HBV感染的自然病史和CHB患者治疗响应的协会。

著录项

来源
《Clinica chimica acta: International journal of clinical chemistry and applied molecular biology》 |2020年第2020期|共8页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类诊断学;
关键词
Albumin-bilirubin; Chronic hepatitis B; Pegylated interferon; Nucleos(t)ide analogues; Natural history; Treatment response;

机译：白蛋白 - 胆红素;慢性乙型肝炎;聚乙二醇化干扰素;核核酸（t）IDE类似物;自然历史;治疗反应;

相似文献

外文文献
中文文献
专利

1. Albumin-bilirubin score is associated with response to pegylated interferon and nucleos(t)ide analogues in chronic hepatitis B patients [J] . Clinica chimica acta: International journal of clinical chemistry and applied molecular biology . 2020,第期

机译：白蛋白 - 胆红素评分与慢性乙型肝炎患者中的聚乙二醇化干扰素和核苷类IDE类似物有关
2. Hepatitis B core-related antigen kinetics in chronic hepatitis B virus genotype D-infected patients treated with nucleos(t)ide analogues or pegylated-interferon- [J] . Caviglia Gian Paolo, Abate Maria Lorena, Noviello Daniele, Hepatology research: the official journal of the Japan Society of Hepatology . 2017,第8期

机译：乙型肝炎核心相关的抗原动力学在慢性乙型肝炎病毒基因型D-感染患者用核核酸（T）IDE类似物或聚乙二醇 - 干扰素 -
3. HbsAg decline and HbsAg seroclearance in chronic hepatitis B patients on nucleos(t)ide analogues or pegylated interferon therapy a systematic review and model-based meta-analysis [J] . Slaets Leen, Verbinnen Thierry, Beumont Maria, Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2017,第Suppla1期

机译：HBsAg下降和HBsAG血管菌在核乙型肝炎患者核核苷酸（T）IDE类似物或聚乙二醇化干扰素治疗中的系统审查和基于模型的荟萃分析
4. Studies of Therapy with Thymosin α 1 in Combination with Pegylated Interferon α2a and Ribavirin in Nonresponder Patients with Chronic Hepatitis C [C] . ROBERTO CAMERINI, ALESSIA CIANCIO, ALFONSO DE ROSA, International Symposiumn on Thymosins in Health and Disease; 20070321-24; Washington,DC(US) . 2007

机译：胸腺素α1联合聚乙二醇化干扰素α2a和利巴韦林治疗慢性丙型肝炎无反应者的研究
5. The meaning of adherence among veterans receiving pegylated interferon and ribavirin antiviral treatment for chronic hepatitis C. [D] . Phillips, Frances Hinshaw. 2011

机译：接受聚乙二醇干扰素和利巴韦林抗病毒治疗的慢性丙型肝炎退伍军人依从性的含义。
6. Early Serum HBsAg Drop Is a Strong Predictor of HBeAg Seroconversion and HBsAg Loss to Pegylated Interferon Alfa-2a in Chronic Hepatitis B Patients with Prior Nucleos(t)ide Analogue Exposure [O] . Qing Chen, Jun Zhang, Jianjun Huang, 2019

机译：早期乙肝类似物暴露的慢性乙型肝炎患者早期血清HBsAg下降是HBeAg血清转化和PEG化干扰素Alfa-2a HBsAg损失的有力预测指标
7. Pegylated Interferon Alfa-2b Add-on Treatment in Hepatitis B Virus Envelope Antigen-Positive Chronic Hepatitis B Patients Treated with Nucleos(t)ide Analogue: A Randomized, Controlled Trial (PEGON) [O] . Heng Chi, Bettina E. Hansen, Simin Guo, 2017

机译：Pegylated干扰素Alfa-2b在乙型肝炎病毒包膜抗原阳性慢性乙型肝炎患者治疗核苷酸（t）IDE模拟：随机，受控试验（PEGON）

Albumin-bilirubin score is associated with response to pegylated interferon and nucleos(t)ide analogues in chronic hepatitis B patients

摘要

著录项

相似文献

相关主题

期刊订阅